What do you need to weigh up when working out whether to get the AstraZeneca vaccine? Here’s what the evidence says.
Academic rigor, journalistic flair
Articles on thrombocytopenia
Displaying all articles
If you have risk factors around blood clots, heart attack or stroke, this should actually be an impetus to get vaccinated sooner rather than later.
One study found antibody levels were significantly higher in people who received one dose of AstraZeneca then a Pfizer booster dose.
If one adenoviral vaccine is linked with blood clots, it doesn’t mean all vaccines in this family will have that same effect. But it’s definitely worth health authorities assessing the data.
Scientists have called it “vaccine-induced prothrombotic immune thrombocytopenia”, or VIPIT. The condition is characterised by a shortage of platelets in the blood.
Top contributors
-
Division Head, Population Health and Immunity, Walter and Eliza Hall Institute
-
Professional Research Fellow, Victoria University
-
Professor of Immunology and Pro Vice-Chancellor, Research Partnerships, Victoria University
-
Vice-Chancellor's Research Fellow, School of Health and Biomedical Sciences, RMIT University
-
Senior Lecturer; MD, Victoria University
-
Senior Principal Research Fellow; paediatrician; infectious diseases epidemiologist; vaccinologist, The University of Melbourne
-
Assistant Professor, General Practice, Bond University
-
Associate professor, Victoria University
-
Clinical researcher, Murdoch Children's Research Institute
-
Professor, Department of Paediatrics, The University of Melbourne
